NVO vs MRK
Novo Nordisk A/S vs Merck & Co. — AI-powered side-by-side comparison
| Metric | NVO | MRK |
|---|---|---|
| AI Score | 56 | 59 |
| Price | $49.48 | $123.48 |
| P/E Ratio | 11.75× | 34.71× |
| ROE | 66.4% | 17.9% |
| Revenue Growth YoY | 8.1% | 2.9% |
| Gross Margin | 81.8% | 78.1% |
| Debt / Equity | 0.67× | 0.94× |
| Dividend Yield | 3.7% | 2.7% |
| RSI (14) | 65.6 | 45.9 |
| Beta | 1.8569 | 0.21 |
| Expected Upside | +25.9% | +0.4% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
NVO Full Analysis
MRK Full Analysis